论文部分内容阅读
目的:研究金双歧联合思密达治疗肝源性腹泻的疗效。方法:将66例肝源性腹泻的病人分为两组,治疗组及对照组各33例。两组均给予适当休息、合理饮食,积极护肝及对症支持等综合治疗;在此基础上,治疗组使用金双歧(2．0g,每日三次)联合思密达(3．0g,每日三次)治疗;对照组口服左氧氟沙星(0．2g,每日两次)治疗。疗程均为7天～14天。疗效判断标准:①显效:腹泻消失,大便成形,每日一次;②有效:腹泻次数明显减少或大便基本成形;③无效:症状无改善或大便次数增多。以显效和有效计算总有效率。结果:治疗组显效13例,有效17例,总有效率90．9%;对照组显效10例,有效6例,总有效率48．5%。两组疗效对比差异有统计学意义(x2=15．45,P＜0．001)。结论:金双歧联合思密达治疗肝源性腹泻疗效显著,值得临床推广应用。
Objective: To study the curative effect of Jinshuangqi combined with Smecta on liver-derived diarrhea. Methods: 66 cases of liver-derived diarrhea patients were divided into two groups, the treatment group and the control group of 33 cases. Both groups were given appropriate rest, a reasonable diet, active liver protection and symptomatic support and other comprehensive treatment; on this basis, the treatment group using bifidobacterium (2.0g, three times daily) combined with Smecta (3.0g, three times a day ); Control group, oral levofloxacin (0.2g, twice daily) treatment. Treatment are 7 days to 14 days. Efficacy criteria: ① markedly: diarrhea disappear, stool shape, once daily; ② effective: significant reduction in the number of diarrhea or stool basic shape; ③ invalid: no improvement in symptoms or increased stool frequency. Effective and effective in calculating the total efficiency. Results: In the treatment group, 13 cases were markedly effective and 17 cases were effective. The total effective rate was 90.9%. In the control group, 10 cases were markedly effective and 6 cases were effective. The total effective rate was 48.5%. The difference between the two groups was statistically significant (x2 = 15.45, P <0.001). Conclusion: Jinshuangqi combined with Smecta treatment of liver-derived diarrhea significant effect, worthy of clinical application.